Detalhe da pesquisa
1.
Organoid models of human and mouse ductal pancreatic cancer.
Cell
; 160(1-2): 324-38, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25557080
2.
Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication.
Pancreatology
; 24(4): 608-615, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749803
3.
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.
Cancer
; 128(15): 2958-2966, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35647938
4.
Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma.
J Surg Oncol
; 125(3): 425-436, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719035
5.
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
Cancer
; 127(23): 4393-4402, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351646
6.
Local Control and Survival After Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma With Vascular Involvement.
Ann Surg
; 274(6): 894-901, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269717
7.
Leptomeningeal disease in pancreas ductal adenocarcinoma: A manifestation of longevity.
Pancreatology
; 21(3): 599-605, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33582005
8.
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma.
Cancer
; 126(17): 3939-3949, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573775
9.
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.
Cancer
; 125(9): 1441-1448, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30620386
10.
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer.
Gastric Cancer
; 22(2): 355-362, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30088161
11.
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.
Cancer
; 124(7): 1374-1382, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29338080
12.
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies.
Invest New Drugs
; 36(4): 683-695, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508247
13.
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.
BMC Cancer
; 18(1): 693, 2018 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945562
14.
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.
Cancer
; 123(23): 4556-4565, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832976
15.
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results.
Oncologist
; 22(12): 1429-e139, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29158367
16.
Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.
Acta Oncol
; 56(12): 1746-1753, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28661823
17.
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
Nature
; 475(7354): 106-9, 2011 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21734707
18.
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
JAMA
; 318(9): 825-835, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28873162
19.
Current management and future directions in metastatic pancreatic adenocarcinoma.
Cancer
; 122(24): 3765-3775, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27649047
20.
Rapidly Fatal Dissemination of Merkel Cell Carcinoma in a Patient Treated with Alemtuzumab for Chronic Lymphocytic Leukemia.
Conn Med
; 80(6): 353-8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27509643